The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNNN.L Regulatory News (NNN)

  • There is currently no data for NNN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

22 Dec 2021 07:00

RNS Number : 4125W
Nanosynth Group PLC
22 December 2021
 

 

22 December 2021

 

nanosynth group plc

("nanosynth", the "Company" or the "Group")

Board change

nanosynth group plc, the AIM quoted company is pleased to announce that Dr Gareth Cave, currently a Non-executive Director of the Company, has today been appointed as an Executive Director and as the Group's Chief Scientific Officer. Dr Cave's intended change of role, which at that time was subject to contract, was announced on 1 September 2021.

Dr Cave is a university chemistry lecturer and has spent his academic career researching many applications of nanotechnology, from drug delivery systems to plant food. Beyond academia, as an active consultant, he shares his knowledge and know-how across a plethora of industries including pharmaceutical, healthcare, materials, agricultural, food and drink industries. In 2015 he formed Pharm 2 Farm Ltd, a wholly owned subsidiary of nanosynth group plc, as a university spinout, to help realise the full commercial potential of this nanotechnology research.

He has B.Sc., M.Sc. and Ph.D. chemistry degrees from the University of Warwick, is an active member of the Royal Society of Chemistry and has worked as an academic in UK, USA and Australian universities over the course of his career.

Mark Duffin, CEO commented: "I am delighted to formalise the agreement for Gareth to become part of the Executive team as Chief Scientific Officer. His skills and experience are ideally suited to guiding us through this exciting and innovative time in the Group's development."

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ('MAR') which has been incorporated into UK law by the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside is now considered to be in the public domain.

 

 

 

 

ENQUIRIES :

nanosynth group plc

Mark Duffin (Chief Executive Officer)

 

via IFC Advisory

SP Angel Corporate Finance LLP 

Nominated Adviser and Broker

Stuart Gledhill

Caroline Rowe

   

+44 20 3470 0470

 

IFC Advisory Ltd

Graham Herring

Zach Cohen

 

+44 20 3934 6630

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADZMZZRMGGMZM
Date   Source Headline
17th Nov 20237:00 amRNSCancellation - Nanosynth Group PLC
14th Nov 20234:10 pmRNSCompany Insolvency
29th Sep 20237:00 amRNSAccounts Update
30th Aug 20233:30 pmRNSAppointment of Joint Broker
30th Aug 20237:00 amRNSResignation of Finance Director
28th Jul 20233:53 pmRNSResignation of Chief Executive Officer
26th Jun 202311:24 amRNSAccounts Update
14th Jun 20233:27 pmRNSNotice re. General Meeting
24th May 20232:27 pmRNSNotice of General Meeting
16th May 202312:28 pmRNSProposal to Appoint Liquidators
16th May 202312:03 pmRNSSuspension - Nanosynth Group plc
28th Apr 20237:00 amRNSHolding(s) in Company
6th Apr 20233:05 pmRNSFinancial Position
31st Jan 20237:00 amRNSTotal Voting Rights
26th Jan 20233:42 pmRNSDirectorate Change
20th Jan 202310:48 amRNSHolding(s) in Company
17th Jan 20237:00 amRNSCorporate and Commercial Update
10th Jan 20237:00 amRNSPlacing and Subscription to raise £0.4 million
4th Jan 20232:56 pmRNSHolding(s) in Company
30th Sep 20227:00 amRNSHalf-year Report
6th Sep 20224:47 pmRNSHolding(s) in Company
1st Sep 20227:00 amRNSTotal Voting Rights
31st Aug 20224:41 pmRNSSecond Price Monitoring Extn
31st Aug 20224:35 pmRNSPrice Monitoring Extension
31st Aug 20222:05 pmRNSSecond Price Monitoring Extn
31st Aug 20222:00 pmRNSPrice Monitoring Extension
31st Aug 202211:05 amRNSSecond Price Monitoring Extn
31st Aug 202211:00 amRNSPrice Monitoring Extension
31st Aug 20229:05 amRNSSecond Price Monitoring Extn
31st Aug 20229:00 amRNSPrice Monitoring Extension
31st Aug 20227:00 amRNSSuccessful Trial Results
30th Aug 20227:00 amRNSJoint Development Agreement in Cosmetics Market
26th Aug 20227:00 amRNSLanstead Subscription and Sharing Agreement
1st Aug 20222:05 pmRNSSecond Price Monitoring Extn
1st Aug 20222:00 pmRNSPrice Monitoring Extension
1st Aug 20221:08 pmRNSPDMR Dealings
26th Jul 20222:41 pmRNSResult of AGM
12th Jul 202211:06 amRNSSecond Price Monitoring Extn
12th Jul 202211:00 amRNSPrice Monitoring Extension
12th Jul 20229:05 amRNSSecond Price Monitoring Extn
12th Jul 20229:00 amRNSPrice Monitoring Extension
11th Jul 20224:40 pmRNSSecond Price Monitoring Extn
11th Jul 20224:36 pmRNSPrice Monitoring Extension
11th Jul 20222:06 pmRNSSecond Price Monitoring Extn
11th Jul 20222:00 pmRNSPrice Monitoring Extension
11th Jul 202211:05 amRNSSecond Price Monitoring Extn
11th Jul 202211:00 amRNSPrice Monitoring Extension
11th Jul 202210:30 amRNSDirector/PDMR dealings
6th Jul 20229:00 amRNSPrice Monitoring Extension
5th Jul 20222:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.